• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺切除术对无功能性肾上腺肿瘤患者高血压的影响:一项回顾性研究。

Impact of adrenalectomy on hypertension in patients with nonfunctional adrenal tumors: a retrospective study.

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

出版信息

World J Urol. 2024 Jul 24;42(1):441. doi: 10.1007/s00345-024-05134-7.

DOI:10.1007/s00345-024-05134-7
PMID:39046549
Abstract

OBJECTIVE

To investigate the impact of adrenalectomy on hypertension in patients with nonfunctional adrenal tumors.

SUBJECTS AND METHODS

Between January 2020 and October 2022, patients with adrenal lesions were retrospectively screened for nonfunctional adrenal tumors at the Zhongnan Hospital of Wuhan University. All patients underwent detailed endocrinological examination and computed tomography to characterize the lesions. One year after discharge, follow-up blood pressure (BP) was assessed and compared to the blood pressure on admission. Univariate analysis and multivariate regression analysis were performed to determine factors predicting favorable hypertension outcomes after adrenalectomy.

RESULTS

A total of 309 patients were found to be eligible, including 123 who underwent adrenalectomy. Patients who underwent adrenalectomy were stratified into two groups: (Bancos I (2022) Adrenal Incidentalomas: Insights Into Prevalence. Ann Intern Med 175:1481-1482. https://doi.org/10.7326/M22-2600 ) those with improved hypertension (n = 71), and (Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J et al. (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1-42. https://doi.org/10.1093/ejendo/lvad066 ) those without improved hypertension (n = 52). In contrast, the blood pressure levels of conservatively treated patients remained relatively stable 1 year after discharge. Univariate analysis and multivariate regression analysis showed that body mass index (BMI) and duration of hypertension were significantly different between the hypertension improvement group and the non-improvement group (p < 0.05).

CONCLUSION

Adrenalectomy has been shown to be effective in improving hypertension in certain patients with nonfunctional adrenal tumors. BMI and duration of hypertension were independent factors associated with favorable hypertension outcomes after adrenalectomy.

摘要

目的

探讨肾上腺切除术对无功能性肾上腺肿瘤患者高血压的影响。

对象与方法

本研究回顾性筛选了 2020 年 1 月至 2022 年 10 月期间在武汉大学中南医院就诊的肾上腺病变患者,所有患者均行详细内分泌检查和 CT 以明确病变特征。出院后 1 年,评估并比较随访血压(BP)与入院时的血压。采用单因素分析和多因素回归分析确定预测肾上腺切除术后高血压良好结局的因素。

结果

共筛选出 309 例符合条件的患者,其中 123 例行肾上腺切除术。将行肾上腺切除术的患者分为两组:(Bancos I(2022)Adrenal Incidentalomas:Insights Into Prevalence. Ann Intern Med 175:1481-1482. https://doi.org/10.7326/M22-2600)血压改善组(n=71)和血压未改善组(n=52)。相比之下,保守治疗患者的血压水平在出院后 1 年仍相对稳定。单因素分析和多因素回归分析显示,血压改善组和未改善组之间的体质指数(BMI)和高血压病程差异有统计学意义(p<0.05)。

结论

肾上腺切除术可有效改善某些无功能性肾上腺肿瘤患者的高血压。BMI 和高血压病程是与肾上腺切除术后高血压良好结局相关的独立因素。

相似文献

1
Impact of adrenalectomy on hypertension in patients with nonfunctional adrenal tumors: a retrospective study.肾上腺切除术对无功能性肾上腺肿瘤患者高血压的影响:一项回顾性研究。
World J Urol. 2024 Jul 24;42(1):441. doi: 10.1007/s00345-024-05134-7.
2
Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma.非功能性肾上腺腺瘤患者行肾上腺部分切除术治疗伴发高血压的疗效
Int Urol Nephrol. 2015 Jan;47(1):59-67. doi: 10.1007/s11255-014-0841-8. Epub 2014 Oct 11.
3
High perioperative morbidity and mortality in patients with malignant nonfunctional adrenal tumors.恶性无功能肾上腺肿瘤患者围手术期的高发病率和死亡率。
J Surg Res. 2017 Nov;219:259-265. doi: 10.1016/j.jss.2017.05.116. Epub 2017 Jul 6.
4
Indications for laparoscopic adrenalectomy for non-functional adrenal tumor with hypertension: usefulness of adrenocortical scintigraphy.腹腔镜肾上腺切除术治疗非功能性肾上腺肿瘤伴高血压的适应证:肾上腺皮质闪烁扫描的应用价值
Int J Urol. 2006 Jun;13(6):677-81. doi: 10.1111/j.1442-2042.2006.01384.x.
5
Laparoscopic surgery in functional and nonfunctional adrenal tumors: A single-center experience.腹腔镜手术治疗功能性和非功能性肾上腺肿瘤:单中心经验
Asian J Surg. 2016 Jul;39(3):137-43. doi: 10.1016/j.asjsur.2015.04.009. Epub 2015 Jul 10.
6
Long-term outcomes of laparoscopic adrenalectomy for adrenal masses.肾上腺肿块腹腔镜肾上腺切除术的长期疗效
J Laparoendosc Adv Surg Tech A. 2015 Mar;25(3):182-6. doi: 10.1089/lap.2014.0430. Epub 2015 Feb 5.
7
Retroperitoneal laparoscopic partial adrenalectomy (RLPA) for 20-40 mm nonfunctional adrenal tumors in the day surgery mode.后腹腔镜下部分肾上腺切除术(RLPA)治疗日间手术模式下 20-40mm 无功能肾上腺肿瘤。
Front Endocrinol (Lausanne). 2022 Dec 20;13:1099818. doi: 10.3389/fendo.2022.1099818. eCollection 2022.
8
Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases.手术时间和肾上腺大小与后腹腔镜肾上腺良性疾病切除术的并发症发生率相关,而与 BMI 无关。
Surgery. 2019 Mar;165(3):637-643. doi: 10.1016/j.surg.2018.09.004. Epub 2018 Oct 25.
9
Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (< or =1 cm): the Ruijin clinical experience in 88 patients.后腹腔镜下肾上腺肿瘤切除术治疗小体积肾上腺肿瘤(<或=1cm):瑞金医院 88 例临床经验
BJU Int. 2010 Mar;105(6):849-53. doi: 10.1111/j.1464-410X.2009.08878.x. Epub 2009 Sep 14.
10
Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients.评估醛固酮消退评分作为法国患者醛固酮瘤肾上腺切除术后高血压预测性消退评分的情况。
Langenbecks Arch Surg. 2017 Mar;402(2):309-314. doi: 10.1007/s00423-017-1557-x. Epub 2017 Jan 22.

引用本文的文献

1
An Analysis of Post-Adrenalectomy Dynamics in MACS (Mild Autonomous Cortisol Secretion)-Positive Adrenal Tumours: The Biomarkers and Clinical Impact.MACS(轻度自主性皮质醇分泌)阳性肾上腺肿瘤肾上腺切除术后动态分析:生物标志物及临床影响
J Clin Med. 2025 Jul 23;14(15):5217. doi: 10.3390/jcm14155217.

本文引用的文献

1
Advances in translational research of the rare cancer type adrenocortical carcinoma.罕见癌症类型肾上腺皮质癌的转化研究进展。
Nat Rev Cancer. 2023 Dec;23(12):805-824. doi: 10.1038/s41568-023-00623-0. Epub 2023 Oct 19.
2
Mortality in Patients With Nonfunctional Adrenal Tumors.无功能性肾上腺肿瘤患者的死亡率。
JAMA Intern Med. 2023 Aug 1;183(8):832-838. doi: 10.1001/jamainternmed.2023.2442.
3
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study.未选择的筛查人群中肾上腺肿瘤的患病率及特征:一项横断面研究
Ann Intern Med. 2022 Oct;175(10):1383-1391. doi: 10.7326/M22-1619. Epub 2022 Sep 13.
4
Adrenal Incidentalomas: Insights Into Prevalence.肾上腺偶发瘤:对患病率的见解
Ann Intern Med. 2022 Oct;175(10):1481-1482. doi: 10.7326/M22-2600. Epub 2022 Sep 13.
5
Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis.无功能性肾上腺腺瘤与糖代谢受损:系统评价和荟萃分析。
Endocrine. 2021 Oct;74(1):50-60. doi: 10.1007/s12020-021-02741-x. Epub 2021 May 7.
6
Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.无功能肾上腺偶发瘤并非临床无症状:一项纵向队列研究。
Endocr Pract. 2020 Dec;26(12):1406-1415. doi: 10.4158/EP-2020-0182.
7
Blood pressure control and progression of arteriosclerosis in hypertension.高血压患者的血压控制与动脉硬化进展。
J Hypertens. 2021 Jun 1;39(6):1221-1229. doi: 10.1097/HJH.0000000000002758.
8
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension.继发性高血压最常见类型的诊断与治疗实践建议
High Blood Press Cardiovasc Prev. 2020 Dec;27(6):547-560. doi: 10.1007/s40292-020-00415-9. Epub 2020 Nov 7.
9
Obesity, metabolic syndrome, and primary hypertension.肥胖症、代谢综合征和原发性高血压。
Pediatr Nephrol. 2021 Apr;36(4):825-837. doi: 10.1007/s00467-020-04579-3. Epub 2020 May 9.
10
Adrenal Incidentaloma.肾上腺意外瘤。
Endocr Rev. 2020 Dec 1;41(6):775-820. doi: 10.1210/endrev/bnaa008.